
Reports
Juvenile Idiopathic Arthritis Therapeutics Market Expands with Rising Biologics Adoption
The global juvenile idiopathic arthritis (JIA) therapeutics market is witnessing a steady rise, with projections estimating its value to reach US$4.4 billion by 2032, up